TBX2 and urinary bladder carcinoma: We found that TBX2 subfamily has differential expression in Bladder Cancer (BLCA), Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Prostate Cancer (PRAD) and Sarcoma (SARC) compared to the matched normal tissues.